2020
DOI: 10.1177/1043454220919713
|View full text |Cite
|
Sign up to set email alerts
|

Psychosocial Interventions for Adolescents and Young Adults With Cancer: An Integrative Review

Abstract: Background: Adolescents and young adults with cancer sit in a precarious position facing an increasing cancer incidence while incidence in other age groups has been declining. A cancer diagnosis at this age imposes undue distress in a demographic with limited coping resources creating psychosocial needs that differ from children and older adults. Addressing psychosocial needs early in the cancer trajectory is postulated as an approach to address distress, improve quality of life, and promote optimal outcomes f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 15 publications
(7 citation statements)
references
References 36 publications
0
7
0
Order By: Relevance
“…Peer support models are recommended as part of best practices to improve youth medication adherence [39,72], reduce disease-related http://onlinelibrary.wiley.com/doi/10.1002/jia2.26148/full | https://doi.org/10.1002/jia2.26148 stigma [73,74] and improve other mental health outcomes [38]. Yet, to the best of our knowledge, the current effectiveness evidence of these models is overwhelmingly derived from approaches that provide peer support to youth living with the same chronic condition [73][74][75][76][77]. Focusing solely on one chronic condition may limit the full potential of peer support groups by preventing youth from capitalizing on the increased knowledge that stems from sharing experiences and disease management habits across conditions.…”
Section: Discussionmentioning
confidence: 99%
“…Peer support models are recommended as part of best practices to improve youth medication adherence [39,72], reduce disease-related http://onlinelibrary.wiley.com/doi/10.1002/jia2.26148/full | https://doi.org/10.1002/jia2.26148 stigma [73,74] and improve other mental health outcomes [38]. Yet, to the best of our knowledge, the current effectiveness evidence of these models is overwhelmingly derived from approaches that provide peer support to youth living with the same chronic condition [73][74][75][76][77]. Focusing solely on one chronic condition may limit the full potential of peer support groups by preventing youth from capitalizing on the increased knowledge that stems from sharing experiences and disease management habits across conditions.…”
Section: Discussionmentioning
confidence: 99%
“…The feasibility of this study was demonstrated by adequate enrollment (67.8%), retention (80.0%), and adherence to the intervention (5.2 out of 6 sessions completed). No a priori benchmarks were established, but the enrollment and retention rates were similar to the prior study of adolescents and young adults newly diagnosed with cancer in a pediatric setting (71% enrollment, 80% retention) [16]. Withdrawal from the study was predominantly due to worsening health and feeling too ill to complete the sessions.…”
Section: Discussionmentioning
confidence: 85%
“…To our knowledge, only one such intervention focused on promoting resilience among newly diagnosed adolescent and young adult patients (aged 12-25 years) in a pediatric setting [17,18]. Results showed improvements in resilience, cancer-specific quality of life, and distress, but may not translate to adult oncology settings or older young adults, given that the sample was from a pediatric oncology setting with the majority of participants being under 18 years of age [16].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…AYAs with cancer report worse severity of stress than younger and older persons with cancer (Kazak et al, 2010); up to 48% of AYAs report posttraumatic stress disorder symptoms during therapy (McCarthy et al, 2016). Stress, distress, and psychosocial functioning alone have adverse effects on toxicity profiles in AYAs during therapy (Haase & Phillips, 2004; Thornton et al, 2020) but may also correlate with higher inflammation. Stress elicits a cascade of proinflammatory responses and, in the oncology population, has been associated with more severe symptom burden (Jakovljevic et al, 2021; Kwekkeboom et al, 2018; Ma et al, 2018; Weber & O’Brien, 2017).…”
mentioning
confidence: 99%